96 related articles for article (PubMed ID: 10772641)
1. Tissue disposition and pharmacokinetics of recombinant human nerve growth factor after acute and chronic subcutaneous administration in monkeys.
Nguyen CB; Harris L; Szönyi E; Baughman SA; Hale VG; Dybdal NO; Sadick MD; Escandón E
Drug Metab Dispos; 2000 May; 28(5):598-607. PubMed ID: 10772641
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of nerve growth factor (NGF) following different routes of administration to adult rats.
Tria MA; Fusco M; Vantini G; Mariot R
Exp Neurol; 1994 Jun; 127(2):178-83. PubMed ID: 8033961
[TBL] [Abstract][Full Text] [Related]
3. Distribution of radioiodinated recombinant human nerve growth factor in primate brain following intracerebroventricular infusion.
Emmett CJ; Stewart GR; Johnson RM; Aswani SP; Chan RL; Jakeman LB
Exp Neurol; 1996 Aug; 140(2):151-60. PubMed ID: 8690058
[TBL] [Abstract][Full Text] [Related]
4. A comparison of mass balance, pharmacokinetics and disposition of [14C(U)]- and [125I]recombinant human interleukin-2 in cynomolgus monkeys.
Nadeau RW; Satoh H; Scheide S; Crowl R; Conroy R; Garland WA; Liberato DJ
Drug Metab Dispos; 1995 Sep; 23(9):904-9. PubMed ID: 8565779
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of human activated protein C. 2nd communication: tissue distribution study of a lyophilized purified human activated protein C after single or repeated intravenous administration in male mice and placental transfer and milk passage study after intravenous administration in pregnant and lactating mice.
Ishii S; Mochizuki T; Nagao T; Kudo S; Fujita A; Taniguchi K; Kondo S; Kiyoki M
Arzneimittelforschung; 1995 May; 45(5):644-56. PubMed ID: 7612069
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human parathyroid hormone 1-34: pharmacokinetics, tissue distribution and excretion in rats.
Hu Z; Niu H; Yang X; Li H; Sang G; Li B
Int J Pharm; 2006 Jul; 317(2):144-54. PubMed ID: 16621369
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
[TBL] [Abstract][Full Text] [Related]
8. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeys.
Zia-Amirhosseini P; Minthorn E; Benincosa LJ; Hart TK; Hottenstein CS; Tobia LA; Davis CB
J Pharmacol Exp Ther; 1999 Dec; 291(3):1060-7. PubMed ID: 10565825
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
Ferraiolo BL; Moore JA; Crase D; Gribling P; Wilking H; Baughman RA
Drug Metab Dispos; 1988; 16(2):270-5. PubMed ID: 2898346
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and hematological effects of the PEGylated thrombopoietin peptide mimetic GW395058 in rats and monkeys after intravenous or subcutaneous administration.
de Serres M; Yeager RL; Dillberger JE; Lalonde G; Gardner GH; Rubens CA; Simkins AH; Sailstad JM; McNulty MJ; Woolley JL
Stem Cells; 1999; 17(6):316-26. PubMed ID: 10606160
[TBL] [Abstract][Full Text] [Related]
12. Regional CNS uptake of blood-borne nerve growth factor.
Loy R; Taglialatela G; Angelucci L; Heyer D; Perez-Polo R
J Neurosci Res; 1994 Oct; 39(3):339-46. PubMed ID: 7869426
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
[TBL] [Abstract][Full Text] [Related]
14. Development of recombinant human nerve growth factor (rhNGF) as a treatment for peripheral neuropathic disease.
Rogers BC
Neurotoxicology; 1996; 17(3-4):865-70. PubMed ID: 9086510
[TBL] [Abstract][Full Text] [Related]
15. Role of neurotrophin signalling in the differentiation of neurons from dorsal root ganglia and sympathetic ganglia.
Ernsberger U
Cell Tissue Res; 2009 Jun; 336(3):349-84. PubMed ID: 19387688
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous dose administration in cynomolgus monkeys.
Ramakrishnan R; Cheung WK; Farrell F; Joffee L; Jusko WJ
J Pharmacol Exp Ther; 2003 Jul; 306(1):324-31. PubMed ID: 12676891
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Jul; 351():1-256. PubMed ID: 12704433
[TBL] [Abstract][Full Text] [Related]
18. Transport and elimination of recombinant human NGF during long-term delivery to the brain.
Krewson CE; Saltzman WM
Brain Res; 1996 Jul; 727(1-2):169-81. PubMed ID: 8842395
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors.
Boinpally RR; Polin L; Zhou SL; Jasti BR; Wiegand RA; White K; Kushner J; Horwitz JP; Corbett TH; Parchment RE
Cancer Chemother Pharmacol; 2003 Jul; 52(1):25-33. PubMed ID: 12739061
[TBL] [Abstract][Full Text] [Related]
20. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
